10-K/A

AMENDMENT TO FORM 10-K

Company: Lineage Cell Therapeutics, Inc.
Filed: April 14, 2003
Period of Report: December 31, 2002
Accession Number: 0000950149-03-000859

View Document ↗ View on SEC.gov ↗